Ehlers S
Dept. of Molecular Infection Biology, Research Center Borstel, Germany.
Infection. 2009 Apr;37(2):87-95. doi: 10.1007/s15010-009-8450-7. Epub 2009 Mar 23.
In the absence of symptoms characteristic of tuberculosis (TB), a condition termed clinical latency, diagnosis is currently impossible by detection of the microorganism itself and resorts to the demonstration of an immunological memory response to antigens of Mycobacterium tuberculosis (Mtb). Whether latency is synonymous to chronic persistent infection with viable Mtb in all instances has been difficult to establish. The physical and physiological state of Mtb during latency is much disputed: are organisms mostly dormant, in a nonreplicating state of persistence, and characterized by lipid inclusions and metabolic adaptation to hypoxia, or do they continue to replicate and sometimes even escape from the fringes of granulomatous lesions or alveolar epithelial cells into adjacent airways, thereby inducing recurring immune responses? The physical nature of Mtb during latency is important as it determines which antimicrobial agents may be used to kill it, which immunomodulating strategies (including post-exposure vaccines) may be appropriate to contain it, and which diagnostic measures may be most useful to discriminate latent from reactivating infection. Two major viewpoints exist: one argues that Mtb persists mostly in a lazy state within granulomatous lesions, but periodically recrudesces, and that there is considerable heterogeneity for different sites within the lesion and within the infected lung. Throughout latency, there is a dynamic immunological interplay between Mtb and the host, necessitating continuous recruitment of cells into the granuloma, and reactivation occurs when this dynamic cellular exchange becomes dysregulated. Another view holds that dormant Mtb reside within alveolar epithelial cells in the lung apices and in adipocytes, with reactivation being associated with the upregulation of resuscitation promoting factors within Mtb and the escape of newly dividing microorganisms into alveoli and bronchi in the form of lipid pneumonia. These views need not be mutually exclusive. However, if minimal intermittent recrudescence were to take place within the alveolar space, this would contradict the very definition of latency, which implies that no access of Mtb to the airways exists during latency.
在没有结核病(TB)特征性症状的情况下,即所谓的临床潜伏状态,目前无法通过检测微生物本身来进行诊断,而是依靠证明对结核分枝杆菌(Mtb)抗原的免疫记忆反应。在所有情况下,潜伏是否等同于由活的Mtb引起的慢性持续感染一直难以确定。潜伏期间Mtb的物理和生理状态存在很大争议:这些微生物大多处于休眠状态,处于非复制性持续状态,以脂质包涵体为特征并对缺氧具有代谢适应性,还是它们继续复制,有时甚至从肉芽肿病变或肺泡上皮细胞边缘逸出进入相邻气道,从而引发反复的免疫反应?潜伏期间Mtb的物理性质很重要,因为它决定了可以使用哪些抗菌剂来杀死它,哪些免疫调节策略(包括暴露后疫苗)可能适合控制它,以及哪些诊断措施可能最有助于区分潜伏感染和再激活感染。存在两种主要观点:一种观点认为,Mtb主要在肉芽肿病变内处于惰性状态,但会周期性复发,并且病变内不同部位以及受感染肺内存在相当大的异质性。在整个潜伏期间,Mtb与宿主之间存在动态免疫相互作用,需要持续将细胞募集到肉芽肿中,当这种动态细胞交换失调时就会发生再激活。另一种观点认为,休眠的Mtb存在于肺尖的肺泡上皮细胞和脂肪细胞中,再激活与Mtb内复苏促进因子的上调以及新分裂的微生物以脂质肺炎的形式逸出到肺泡和支气管有关。这些观点不一定相互排斥。然而,如果在肺泡腔内发生最小程度的间歇性复发,这将与潜伏的定义相矛盾,潜伏意味着在潜伏期间Mtb无法进入气道。